Antibiotics before fecal transplant for IBS
Part of Digestive system clinical trials.
This study tests whether taking antibiotics before a fecal microbiota transplant (WMT) can improve symptoms of irritable bowel syndrome (IBS). It may help patients with IBS who have not found relief from other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with IBS using the Rome IV criteria (recurring belly pain or discomfort linked to bowel movements, changes in stool frequency or appearance).
- You are willing to stop certain medications that affect gut movement or gut bacteria, like probiotics or antibiotics, during the study.
- You have had a colonoscopy in the last 2 years that showed no serious gut diseases like tumors or Crohn's disease.
- You do not have severe heart, lung, or liver problems, active infections, or an ongoing need for certain drugs.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether fecal microbiota transplantation (a stool-based treatment to change gut bacteria) can reduce symptoms of irritable bowel syndrome (IBS) that comes with diarrhea. You may be eligible if you’re an adult with diarrhea-predominant IBS and recent colonoscopy results that rule out other intestinal diseases.
This study tests whether a fecal microbiota transplant (FMT) — transferring healthy stool bacteria into your gut — can help people with severe irritable bowel syndrome (IBS) that hasn't improved after trying at least two other treatments.
This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.
This study tests whether transferring stool bacteria from a healthy donor (fecal microbiota transplantation) can improve symptoms of irritable bowel syndrome (IBS). It may help by changing the gut bacteria that can influence digestion and gut discomfort.
This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.
This trial tests whether transferring stool bacteria to the gut (fecal microbiota transplantation) can reduce symptoms of irritable bowel syndrome with constipation. It may help by changing the gut microbiome, but you must meet safety and health requirements.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.